I am researching for my capstone and I am struggling with developing a PICOT question. My topic is IM injections, and making the ventrogluteal site the site of choice for injections (basically to maybe implement a policy to say use this site whenever possible). I'm looking at the risks with the dorsogluteal site, and not sure if that should be part of my PICOT or not (sciatic nerve injury, injecting into the sub-q space in obese patients, etc.). So my areas are as follows:
P = nurses
I = ventrogluteal IM injections
C = compared to dorsogluteal injections
O = ????
T = not sure what a good time frame is.....6 months, 1 year....?
Thanks so much for any assistance!
Featured Replies
Join the conversation
You can post now and register later.
If you have an account, sign in now to post with your account.
Hello everyone,
I am researching for my capstone and I am struggling with developing a PICOT question. My topic is IM injections, and making the ventrogluteal site the site of choice for injections (basically to maybe implement a policy to say use this site whenever possible). I'm looking at the risks with the dorsogluteal site, and not sure if that should be part of my PICOT or not (sciatic nerve injury, injecting into the sub-q space in obese patients, etc.). So my areas are as follows:
P = nurses
I = ventrogluteal IM injections
C = compared to dorsogluteal injections
O = ????
T = not sure what a good time frame is.....6 months, 1 year....?
Thanks so much for any assistance!